Edwards Lifesciences (EW)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-09-11 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Edwards Lifesciences Corp (EW) CIK: 0001099800 --- Reporting Owner --- Name: Markowitz Wayne CIK: 0001991414 Role: Officer (CVP, JAPAC) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-09-11 | Code: F (Payment of exercise/tax) Shares: -355 | Price: $86.77 Total Value: $30,803.35 Shares Owned After: 19,938.5581 | Ownership: D (Direct) Footnotes: [F1] Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e). [Transaction #2] Security: Common Stock Date: 2026-09-14 | Code: F (Payment of exercise/tax) Shares: -568 | Price: $84.37 Total Value: $47,922.16 Shares Owned After: 19,370.5581 | Ownership: D (Direct) Footnotes: [F1] Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e). --- Footnotes (Complete Index) --- F1: Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e). --- Signature --- /s/ Linda J. Park, Attorney-in-Fact (2026-09-14)